New York, Feb 8, 2026, 16:37 EST — The bell’s rung; trading has wrapped for the day.
- Linde ended the session at $448.07, slipping 2.53%.
- JPMorgan downgraded the stock to Neutral, pointing to valuation concerns and a pause in sequential pricing gains.
- Now, investors are eyeing upcoming U.S. jobs and inflation numbers, with Linde’s conference dates set for Feb. 17–18 also on the radar.
Linde plc shares are set to start Monday under pressure, following a 2.53% drop to $448.07 by Friday’s close. That move came as a new Wall Street downgrade piled onto the stock’s post-earnings slide.
This shift is drawing focus, as Linde’s outlook now sits at the heart of the debate for a stock long treated as a high-quality “steady compounder” in chemicals. The world’s top industrial gases group cleared fourth-quarter estimates, but investors wasted little time probing just how much pricing strength and efficiency will drive earnings into 2026. Reuters earnings story
Linde supplies oxygen, nitrogen, and hydrogen to both factories and hospitals—traders frequently use the stock as a gauge for industrial demand. Discussion lately has zeroed in on pricing: can the company keep raising prices each quarter without sacrificing sales volumes?
JPMorgan cut Linde to Neutral from Overweight, holding its $455 target but flagging valuation concerns and what it described as pricing pressure. According to the bank, Linde’s consolidated prices haven’t budged for two quarters in a row—likely a reflection of softer helium prices. That static pricing could keep Linde’s valuation multiple from moving higher unless things pick up.
UBS shrugged off caution, sticking with its Buy call and hiking the price target to $550. Morgan Stanley also bumped its target, now $530, and repeated Overweight. The firm pointed to project launches and improved productivity as likely drivers for 2026.
Linde set its sights on 2026 adjusted earnings per share in the $17.40 to $17.90 range, while first-quarter adjusted EPS is pegged between $4.20 and $4.30. CEO Sanjiv Lamba noted that for 2025, operating profit, cash flow and backlog all topped $10 billion. For capital spending, the group is looking at $5.0 billion to $5.5 billion in 2026.
Linde handed in its earnings release via an 8-K to the SEC on Feb. 5, according to the filing.
Friday saw Linde shares move lower, even as the broader indexes posted sizable gains—the S&P 500 added 1.97%, and the Dow surged 2.47%. Air Products hovered near flat.
Near-term downside for Linde bulls is clear enough: should pricing hold steady and industrial demand fail to pick up, that premium “defensive growth” multiple could come under pressure, backlog and buybacks notwithstanding.
The calendar leaves little room for delay. Linde is set to present at Citi’s 2026 Global Industrial Tech and Mobility Conference on Feb. 17, then turn around for Barclays’ 43rd Annual Industrial Select Conference the next day, Feb. 18, per the company’s events page.
Macro headlines may hit early. The Labor Department’s calendar shows the U.S. January jobs report landing on Feb. 11, with January CPI following on Feb. 13 — numbers that can jolt rate bets and move sentiment fast, especially for industrial-exposed stocks.
Monday brings attention back to LIN, as traders look to see if shares can stabilize after the downgrades knocked them back. Eyes are on the $455 level JPMorgan flagged, with another spate of conferences and fresh U.S. data coming up.
